Table 5.
Quality of dispensing for patients that received an ACT
| Public | Medicine retailer | Total | ||
|---|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | P value | |
| All febrile patients that received an ACT* | N = 100 | N = 176 | N = 276 | |
| % accurate dose† | 75.8 (70.6-80.2) | 65.5 (50.1-78.1) | 66.2 (51.8-78.0) | 0.135 |
| % patient has accurate knowledge of treatment regimen‡ i | 68.3 (63.7-72.6) | 58.5 (41.6-73.6) | 59.2 (43.4-73.3) | 0.218 |
| % patients with accurate dose and knowledge of treatment regimenii | 66.8 (61.3-71.9) | 57.2 (40.3-72.5) | 57.8 (41.7-72.4) | 0.236 |
| % patients that reported were told of side effectsiii | 1.5 (1.2-1.9) | 3.0 (0.6-14.0) | 3.0 (0.6-12.9) | 0.357 |
| Febrile adults that received an ACT* | N = 21 | N = 125 | N = 146 | |
| % in accurate dose† | 72.8 (68.6-76.6) | 62.0 (43.5-77.5) | 62.2 (44.2-77.4) | 0.165 |
| % patient has accurate knowledge of treatment regimen‡ iv | 72.8 (68.6-76.6) | 55.4 (36.3-73.0) | 55.8 (37.1-73.0) | 0.051 |
| % patients with accurate dose and knowledge of treatment regimeniv | 72.8 (68.6-76.6) | 55.4 (36.3-73.0) | 55.8 (37.1-73.0) | 0.051 |
| % patients that reported were told of side effectsv | 6.2 (5.0-7.7) | 4.2 (0.8-18.5) | 4.2 (0.9-17.8) | 0.570 |
* excludes suspensions and syrups and limited to cases for which have data on dosage
† defined as dose that is consistent guidance on dosage by patient age.
‡ defined as patient reports treatment regimen is consistent with guidance on dosage by patient age
i missing 10 observations (2 from public and 8 from medicine retailers)
ii missing 12 observations (4 from public and 8 from medicine retailers)
iii missing 6 observations (2 from public and 4 from medicine retailers)
iv missing 2 observations (from medicine retailers)
v missing 3 observations (from medicine retailers)